|Articles|September 1, 2002
- Applied Clinical Trials-09-01-2002
Using Adaptive Interim Analysis to Calculate Sample Size in a Trial of a Treatment for Erectile Dysfunction
Adaptive interim analysis may allow smaller sample sizes when a drug?s clinical effect is unknown.
Advertisement
Articles in this issue
over 23 years ago
EU as Physician Rather than Police Officerover 23 years ago
Radiology in Oncology Trials: Critical Success Factorsover 23 years ago
Changing Current Practiceover 23 years ago
Coping with the Cost of Prescription Benefitsover 23 years ago
EORTC's Regulatory Affairs Unitover 23 years ago
Building and Maintaining Monitor-Coordinator Relationshipsover 23 years ago
Ethnicity in Drug Development and TherapeuticsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup
2
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
3
Targeted and Strategy-Driven Clinical Development
4
ACT Brief: FDA’s Agentic AI Rollout, Exercise Interventions for Long COVID, and Patient-Centered Evidence Beyond the Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
